IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Pergolide Treatment for Substance Abusers - 4
This study has been completed.
Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
New York State Psychiatric Institute
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000269
First received: September 20, 1999
Last updated: January 11, 2017
Last verified: November 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.
| Condition | Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Substance-Related Disorders | Drug: Pergolide | Phase 2 |
| Study Type: | Interventional |
| Study Design: | Primary Purpose: Treatment |
| Official Title: | Pergolide Treatment for Substance Abusers |
Resource links provided by NLM:
Further study details as provided by National Institute on Drug Abuse (NIDA):
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
Please contact site for information.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000269
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000269
Locations
| United States, New York | |
| New York State Psychiatric Institute | |
| New York, New York, United States, 10032 | |
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute
Investigators
| Principal Investigator: | Herbert Kleber, M.D. | New York State Psychiatric Institute |
More Information
| ClinicalTrials.gov Identifier: | NCT00000269 History of Changes |
| Other Study ID Numbers: |
NIDA-09236-4 P50-09236-4 |
| Study First Received: | September 20, 1999 |
| Last Updated: | January 11, 2017 |
Keywords provided by National Institute on Drug Abuse (NIDA):
|
cocaine dependence |
Additional relevant MeSH terms:
|
Disease Substance-Related Disorders Cocaine-Related Disorders Pathologic Processes Chemically-Induced Disorders Mental Disorders |
Pergolide Dopamine Agonists Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on July 27, 2017